metastatic malignant solid neoplasm

Showing NaN - NaN of 17

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Endometrial Serous Adenocarcinoma, Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in United States

Recruiting
  • Endometrial Serous Adenocarcinoma
  • +2 more
  • Biopsy
  • +3 more
  • Phoenix, Arizona
  • +3 more
Feb 2, 2023

Advanced Malignant Solid Tumor, Autoimmune Disease, Crohn Disease Trial in Canada, United States (Nivolumab)

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +15 more
  • Biospecimen Collection
  • Nivolumab
  • Birmingham, Alabama
  • +46 more
Jan 31, 2023

Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in New Haven (procedure, drug, biological)

Recruiting
  • Metastatic Malignant Solid Neoplasm
  • Unresectable Malignant Solid Neoplasm
  • Biopsy
  • +2 more
  • Boston, Massachusetts
  • +2 more
Jan 25, 2023

HER2-Positive Breast Carcinoma, Metastatic Malignant Solid Tumor, Refractory Malignant Solid Tumor Trial in United States

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +4 more
  • Biopsy
  • +3 more
  • Bethesda, Maryland
  • +4 more
Jan 21, 2023

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Refractory Malignant Solid Tumor Trial in Canada, United

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +2 more
  • Biopsy
  • +6 more
  • Boston, Massachusetts
  • +5 more
Jan 7, 2023

Advanced Malignant Solid Tumor, HIV Infection, Metastatic Malignant Solid Tumor Trial in United States (Cabozantinib S-malate,

Completed
  • Advanced Malignant Solid Neoplasm
  • +4 more
  • Cabozantinib S-malate
  • +2 more
  • La Jolla, California
  • +19 more
Dec 14, 2022

Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Colorectal Carcinoma, Metastatic Malignant Solid Tumor Trial in Canada,

Active, not recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +20 more
  • Pembrolizumab
  • Ziv-Aflibercept
  • Tampa, Florida
  • +8 more
Jan 3, 2023

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in United States

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +2 more
  • Biopsy
  • +7 more
  • Aurora, Colorado
  • +7 more
Nov 29, 2022

Metastatic Malignant Solid Tumor, Refractory Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in Boston

Active, not recruiting
  • Metastatic Malignant Solid Neoplasm
  • +2 more
  • Biopsy
  • +6 more
  • Boston, Massachusetts
  • +1 more
Nov 8, 2022

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Unresectable Solid Tumor Trial in United States (CDK Inhibitor

Active, not recruiting
  • Advanced Malignant Solid Neoplasm
  • +2 more
  • CDK Inhibitor AT7519
  • +3 more
  • Washington, District of Columbia
  • +5 more
Oct 18, 2022

Metastatic Malignant Solid Tumor, Recurrent Lung Small Cell Carcinoma, Recurrent Malignant Solid Tumor Trial in United States

Terminated
  • Metastatic Malignant Solid Neoplasm
  • +8 more
  • Los Angeles, California
  • +13 more
Oct 7, 2022

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Refractory Malignant Solid Tumor Trial in Boston, Galveston,

Suspended
  • Advanced Malignant Solid Neoplasm
  • +4 more
  • Boston, Massachusetts
  • +2 more
Oct 5, 2022

Metastatic Malignant Solid Tumor, Metastatic NUT Carcinoma, Unresectable Malignant Solid Tumor Trial (Abemaciclib, BET

Suspended
  • Metastatic Malignant Solid Neoplasm
  • +3 more
  • Boston, Massachusetts
    Dana-Farber - Harvard Cancer Center LAO
Sep 17, 2022

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, NF1 Mutation Positive Malignant Peripheral Nerve Sheath Tumor

Active, not recruiting
  • Advanced Malignant Solid Neoplasm
  • +3 more
  • Pharmacodynamic Study
  • Telaglenastat Hydrochloride
  • Birmingham, Alabama
  • +30 more
Sep 1, 2022

NCI COVID-19 in Cancer Patients, NCCAPS Study

Active, not recruiting
  • COVID-19 Infection
  • +3 more
  • Biospecimen Collection
  • +3 more
  • Birmingham, Alabama
  • +940 more
Aug 5, 2022

Metastatic Colorectal Carcinoma, Metastatic Lung Carcinoma, Metastatic Lung Small Cell Carcinoma Trial in United States

Recruiting
  • Metastatic Colorectal Carcinoma
  • +29 more
  • Los Angeles, California
  • +22 more
Jun 28, 2022

BRAF V600E Mutation Present, BRAF V600K Mutation Present, Metastatic Malignant Solid Tumor Trial in Boston (Dabrafenib,

Active, not recruiting
  • BRAF V600E Mutation Present
  • +9 more
  • Boston, Massachusetts
  • +1 more
Jun 28, 2022